These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9398350)
21. Development of an enzyme-linked-receptor assay based on Syrian hamster β2-adrenergic receptor for detection of β-agonists. Cheng G; Li F; Peng D; Huang L; Hao H; Liu Z; Wang Y; Yuan Z Anal Biochem; 2014 Aug; 459():18-23. PubMed ID: 24853343 [TBL] [Abstract][Full Text] [Related]
22. Expression of Codon Optimized β Liu Y; Wang J; Liu Y; Yang L; Zhu X; Wang W; Zhang J; Wei D J Microbiol Biotechnol; 2019 Sep; 29(9):1470-1477. PubMed ID: 31434365 [TBL] [Abstract][Full Text] [Related]
23. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells. Nakanishi J; Takarada T; Yunoki S; Kikuchi Y; Maeda M Biochem Biophys Res Commun; 2006 May; 343(4):1191-6. PubMed ID: 16580633 [TBL] [Abstract][Full Text] [Related]
24. A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. Hebert TE; Moffett S; Morello JP; Loisel TP; Bichet DG; Barret C; Bouvier M J Biol Chem; 1996 Jul; 271(27):16384-92. PubMed ID: 8663163 [TBL] [Abstract][Full Text] [Related]
25. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Yao X; Parnot C; Deupi X; Ratnala VR; Swaminath G; Farrens D; Kobilka B Nat Chem Biol; 2006 Aug; 2(8):417-22. PubMed ID: 16799554 [TBL] [Abstract][Full Text] [Related]
26. Examination of ligand-induced conformational changes in the beta 2-adrenergic receptor by fluorescence spectroscopy. Kobilka BK; Gether U Adv Pharmacol; 1998; 42():470-3. PubMed ID: 9327941 [No Abstract] [Full Text] [Related]
27. Amino and carboxyl terminal modifications to facilitate the production and purification of a G protein-coupled receptor. Kobilka BK Anal Biochem; 1995 Oct; 231(1):269-71. PubMed ID: 8678314 [No Abstract] [Full Text] [Related]
28. Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor. Gether U; Lin S; Ghanouni P; Ballesteros JA; Weinstein H; Kobilka BK EMBO J; 1997 Nov; 16(22):6737-47. PubMed ID: 9362488 [TBL] [Abstract][Full Text] [Related]
29. Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. Gether U; Ballesteros JA; Seifert R; Sanders-Bush E; Weinstein H; Kobilka BK J Biol Chem; 1997 Jan; 272(5):2587-90. PubMed ID: 9006889 [TBL] [Abstract][Full Text] [Related]
30. Examination of ligand-induced conformational changes in the beta2 adrenergic receptor. Kobilka B; Gether U; Seifert R; Lin S; Ghanouni P Life Sci; 1998; 62(17-18):1509-12. PubMed ID: 9585127 [TBL] [Abstract][Full Text] [Related]
31. Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies. Granier S; Kim S; Shafer AM; Ratnala VR; Fung JJ; Zare RN; Kobilka B J Biol Chem; 2007 May; 282(18):13895-905. PubMed ID: 17347144 [TBL] [Abstract][Full Text] [Related]
32. Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Trester-Zedlitz M; Burlingame A; Kobilka B; von Zastrow M Biochemistry; 2005 Apr; 44(16):6133-43. PubMed ID: 15835901 [TBL] [Abstract][Full Text] [Related]
33. Tyr199 in transmembrane domain 5 of the beta2-adrenergic receptor interacts directly with the pharmacophore of a unique fluorenone-based antagonist. Wu Z; Thiriot DS; Ruoho AE Biochem J; 2001 Mar; 354(Pt 3):485-91. PubMed ID: 11237852 [TBL] [Abstract][Full Text] [Related]
34. Use of fluorescence spectroscopy to study conformational changes in the beta 2-adrenoceptor. Kobilka BK; Gether U Methods Enzymol; 2002; 343():170-82. PubMed ID: 11665566 [No Abstract] [Full Text] [Related]
35. A novel sorting sequence in the beta2-adrenergic receptor switches recycling from default to the Hrs-dependent mechanism. Hanyaloglu AC; von Zastrow M J Biol Chem; 2007 Feb; 282(5):3095-104. PubMed ID: 17138565 [TBL] [Abstract][Full Text] [Related]
36. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. Jensen AD; Guarnieri F; Rasmussen SG; Asmar F; Ballesteros JA; Gether U J Biol Chem; 2001 Mar; 276(12):9279-90. PubMed ID: 11118431 [TBL] [Abstract][Full Text] [Related]
37. Dynamics of beta2-adrenergic receptor-ligand complexes on living cells. Hegener O; Prenner L; Runkel F; Baader SL; Kappler J; Häberlein H Biochemistry; 2004 May; 43(20):6190-9. PubMed ID: 15147203 [TBL] [Abstract][Full Text] [Related]
38. Reversible and site-specific immobilization of β Gao J; Chang Z; Tian R; Li P; Ahmad F; Jia X; Liang Q; Zhao X J Chromatogr A; 2020 Jul; 1622():461091. PubMed ID: 32376022 [TBL] [Abstract][Full Text] [Related]
39. Long-wavelength absorbing and fluorescent chameleon labels for proteins, peptides, and amines. Gorris HH; Saleh SM; Groegel DB; Ernst S; Reiner K; Mustroph H; Wolfbeis OS Bioconjug Chem; 2011 Jul; 22(7):1433-7. PubMed ID: 21671666 [TBL] [Abstract][Full Text] [Related]
40. Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor. Zocher M; Zhang C; Rasmussen SG; Kobilka BK; Müller DJ Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3463-72. PubMed ID: 23151510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]